Glucotrack (GCTK) Gains from Investment Securities (2012 - 2018)
Glucotrack (GCTK) posted Gains from Investment Securities of $6.9 million for Q4 2018, up 7566.91% on a QoQ basis from -$91762.0 in Q3 2018, and up 25869.27% year-over-year from N/an in Q4 2017.
Glucotrack (GCTK) Gains from Investment Securities (2012 - 2018) Analysis & Trends
Glucotrack's Gains from Investment Securities history runs 7 years deep, the most recent figure standing at $6.9 million for Q4 2018.
- Quarterly Gains from Investment Securities rose 25869.27% year-over-year to $6.9 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $6.6 million (up 2297.64% YoY) and the FY2018 annual result came in at $6.6 million, up 2297.64% from the prior year.
- Gains from Investment Securities was $6.9 million for Q4 2018 at Glucotrack, up from -$91762.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $6.9 million in Q4 2018 and bottomed at -$6.1 million in Q2 2014.
- A 5-year average of -$16135.8 and a median of -$65770.0 in 2015 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2014 — Gains from Investment Securities slumped 2692.79% — and 2018, when it jumped 25869.27%.
- Glucotrack's Gains from Investment Securities stood at -$50635.0 in 2014, then surged by 45.02% to -$27839.0 in 2015, then slumped by 66.26% to -$46286.0 in 2016, then surged by 42.55% to -$26589.0 in 2017, then soared by 25869.27% to $6.9 million in 2018.
- Business Quant data shows GCTK's Gains from Investment Securities at $6.9 million in Q4 2018, -$91762.0 in Q3 2018, and -$82081.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Glucotrack | 186,390.31 | -7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 6.85 Mn |
| Dec 31, 2018 | 6.85 Mn |
| Sep 30, 2018 | -91,762.00 |
| Sep 30, 2018 | -91,762.00 |
| Jun 30, 2018 | -82,081.00 |
| Jun 30, 2018 | -82,081.00 |
| Mar 31, 2018 | -77,947.00 |
| Mar 31, 2018 | -77,947.00 |
| Dec 31, 2017 | -26,589.00 |
| Dec 31, 2017 | -26,589.00 |
| Sep 30, 2017 | -82,658.00 |
| Sep 30, 2017 | -82,658.00 |
| Jun 30, 2017 | -106,976.00 |
| Jun 30, 2017 | -106,976.00 |
| Mar 31, 2017 | -84,099.00 |
| Mar 31, 2017 | -84,099.00 |
| Sep 30, 2016 | -46,286.00 |
| Sep 30, 2016 | -46,286.00 |
| Jun 30, 2016 | -20,702.00 |
| Jun 30, 2016 | -20,702.00 |